A Study Comparing the Efficacy and Safety of OROS® Oxybutynin to That of Ditropan® (Immediate-release Oxybutynin) for the Treatment of Patients With Urge or Mixed Urinary Incontinence.

PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

July 31, 1996

Study Completion Date

February 28, 1997

Conditions

Urge Incontinence

Interventions

DRUG

OROS® oxybutynin or Ditropan®

All Listed Sponsors

lead

Alza Corporation, DE, USA

INDUSTRY